Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02392234
Brief Title: A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

First Submitted : March 12, 2015
First Submitted that Met QC Criteria : March 12, 2015
First Posted : March 18, 2015 (Estimate)

Results First Submitted : March 14, 2018
Results First Submitted that Met QC Criteria : May 8, 2018
Results First Posted : June 12, 2018

Certification/Extension First Submitted : February 12, 2018
Certification/Extension First Submitted that Met QC Criteria : February 12, 2018
Certification/Extension First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : May 8, 2018
Last Update Posted : June 12, 2018